Steady states and oscillations in the p53/Mdm2 network

被引:186
|
作者
Ciliberto, A
Novak, B
Tyson, JJ
机构
[1] Hungarian Acad Sci, Mol Network Dynam Res Grp, Budapest, Hungary
[2] Budapest Univ Technol & Econ, Budapest, Hungary
[3] Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA
关键词
network dynamics; signal transduction; feedback control; tumor suppressors; p53;
D O I
10.4161/cc.4.3.1548
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p53 is activated in response to events compromising the genetic integrity of a cell. Recent data show that p53 activity does not increase steadily with genetic damage but rather fluctuates in an oscillatory fashion. 7 Theoretical studies suggest that oscillations can arise from a combination of positive and negative feedbacks or from a long negative feedback loop alone. Both negative and positive feedbacks are present in the p53/Mdm2 network, but it is not known what roles they play in the oscillatory response to DNA damage. We developed a mathematical model of p53 oscillations based on positive and negative feedbacks in the p53/Mdm2 network. According to the model, the system reacts to DNA damage by moving from a stable steady state into a region of stable limit cycles. Oscillations in the model are born with large amplitude, which guarantees an all-or-none response to damage. As p53 oscillates, damage is repaired and the system moves back to a stable steady state with low p53 activity. The model reproduces experimental data in quantitative detail. We suggest new experiments for dissecting the contributions of negative and positive feedbacks to the generation of oscillations.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [41] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006
  • [42] p53 mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
    Karakostis, Konstantinos
    Ponnuswamy, Anand
    Fusee, Leila T. S.
    Bailly, Xavier
    Laguerre, Laurent
    Worall, Erin
    Vojtesek, Borek
    Nylander, Karin
    Fahraeus, Robin
    MOLECULAR BIOLOGY AND EVOLUTION, 2016, 33 (05) : 1280 - 1292
  • [43] Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors
    Yokoyama, R
    Schneider-Stork, R
    Radig, K
    Wex, T
    Roessner, A
    PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (09) : 615 - 621
  • [44] MDM2 and MDM4: p53 regulators as targets in anticancer therapy
    Toledo, Franck
    Wahl, Geoffrey M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8) : 1476 - 1482
  • [45] p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas
    Pacinda, SJ
    Ledet, SC
    Gondo, MM
    Langston, C
    Brown, RW
    Carmona, PA
    Franklin, RB
    Roggli, VL
    Cagle, PT
    HUMAN PATHOLOGY, 1996, 27 (06) : 542 - 546
  • [46] The MDM2/MDMX/p53 axis in the adaptive stress response
    Wang, Bing
    Rasmussen-Ivey, Cody
    Little, John B.
    Yuan, Zhi-Min
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1993 - 1997
  • [47] p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
    Huang, Youyi
    Che, Xiaofang
    Wang, Peter W.
    Qu, Xiujuan
    SEMINARS IN CANCER BIOLOGY, 2024, 101 : 44 - 57
  • [48] Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
    Twala, Charmy
    Malindisa, Sibusiso
    Munnik, Chamone
    Sooklal, Selisha
    Ntwasa, Monde
    BIOMEDICINES, 2025, 13 (01)
  • [49] The role of the MDM2/p53 axis in antitumor immune responses
    Brummer, Tilman
    Zeiser, Robert
    BLOOD, 2024, 143 (26) : 2701 - 2709
  • [50] p53 and MDM2 are involved in the regulation of osteocalcin gene expression
    Chen, Hankui
    Kolman, Kevin
    Lanciloti, Natalie
    Nerney, Michael
    Hays, Emily
    Robson, Chet
    Chandar, Nalini
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (08) : 867 - 876